Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Scherl

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Crohn'S & Colitis 360|February 13, 2023
Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn's Disease and 2 Years in Ulcerative ColitisBincy P Abraham, Elyssa Ott, Christopher Busse, et al.
The American Journal of Gastroenterology|April 20, 2004
The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patientsDavid Norman Moskovitz, Carol Bodian, Mark L Chapman, et al.
Digestive Diseases and Sciences|June 8, 2018
Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease PatientsShirley Cohen-Mekelburg, Stephanie Gold, Yecheskel Schneider, et al.
Digestive Diseases and Sciences|May 16, 2018
Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel DiseaseShirley Cohen-Mekelburg, Zaid Tafesh, Elliot Coburn, et al.
Journal of Clinical Gastroenterology|August 30, 2023
The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's DiseaseEmily S Smith, Johnson Chen, Yushan Pan, et al.
Journal of Crohn'S & Colitis|May 10, 2018
The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease PatientsShirley Cohen-Mekelburg, Russell Rosenblatt, Stephanie Gold, et al.
Gastroenterology|August 19, 2008
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's diseaseWilliam J Sandborn, Brian G Feagan, Richard N Fedorak, et al.
The American Journal of Gastroenterology|November 14, 2018
Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse OutcomesShirley Cohen-Mekelburg, Russell Rosenblatt, Stephanie Gold, et al.
Digestive Diseases and Sciences|March 1, 2019
Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease CareShirley Cohen-Mekelburg, Yecheskel Schneider, Stephanie Gold, et al.
The American Journal of Managed Care|October 18, 2019
Inflammatory bowel disease readmissions are associated with utilization and comorbidityShirley Cohen-Mekelburg, Russell Rosenblatt, Beth Wallace, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Crohn'S & Colitis 360|February 13, 2023
Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn's Disease and 2 Years in Ulcerative ColitisBincy P Abraham, Elyssa Ott, Christopher Busse, et al.
The American Journal of Gastroenterology|April 20, 2004
The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patientsDavid Norman Moskovitz, Carol Bodian, Mark L Chapman, et al.
Digestive Diseases and Sciences|June 8, 2018
Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease PatientsShirley Cohen-Mekelburg, Stephanie Gold, Yecheskel Schneider, et al.
Digestive Diseases and Sciences|May 16, 2018
Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel DiseaseShirley Cohen-Mekelburg, Zaid Tafesh, Elliot Coburn, et al.
Journal of Clinical Gastroenterology|August 30, 2023
The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's DiseaseEmily S Smith, Johnson Chen, Yushan Pan, et al.
Journal of Crohn'S & Colitis|May 10, 2018
The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease PatientsShirley Cohen-Mekelburg, Russell Rosenblatt, Stephanie Gold, et al.
Gastroenterology|August 19, 2008
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's diseaseWilliam J Sandborn, Brian G Feagan, Richard N Fedorak, et al.
The American Journal of Gastroenterology|November 14, 2018
Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse OutcomesShirley Cohen-Mekelburg, Russell Rosenblatt, Stephanie Gold, et al.
Digestive Diseases and Sciences|March 1, 2019
Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease CareShirley Cohen-Mekelburg, Yecheskel Schneider, Stephanie Gold, et al.
The American Journal of Managed Care|October 18, 2019
Inflammatory bowel disease readmissions are associated with utilization and comorbidityShirley Cohen-Mekelburg, Russell Rosenblatt, Beth Wallace, et al.
Pageof 6